Company research / LUNG

Pulmonx Corp (LUNG)

CIK 0001127537 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Pulmonx Corp reported revenue of $90.50M. Revenue grew 8.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

74.2%
Gross margin
-59.3%
Operating margin
-59.7%
Net margin
-99.8%
Return on year-end equity
8.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-03

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.